RETRACTION: physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis (Retraction of Vol 104, Pg 28, 2018)

被引：0

作者：

Wang, Qiang ^{[1
]}

Yan, Yi ^{[1
]}

Zhang, Jie ^{[1
]}

Guo, Peng ^{[1
]}

Xing, Yuqing ^{[1
]}

Wang, Yong ^{[1
]}

Qin, Fawei ^{[1
]}

Zeng, Qingyun ^{[2
]}

机构：

[1] Shandong Univ, Shandong Prov Hosp, Jinan, Shandong, Peoples R China

[2] Shandong Univ Tradit Chinese Med, Hosp Affiliated, Jinan, Shandong, Peoples R China

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2021年 / 134卷

关键词：

D O I：

10.1016/j.biopha.2020.111070

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页数：1

共 47 条

[1] RETRACTED: Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis (Retracted article. See vol. 134, 2021)
Wang, Qiang
Yan, Yi
Zhang, Jie
Guo, Peng
Xing, Yuqing
Wang, Yong
Qin, Fawei
Zeng, Qingyun
BIOMEDICINE & PHARMACOTHERAPY, 2018, 104 : 28 - 35
[2] RETRACTION: Physcion 8-O-β-glucopyranoside suppresses tumor growth of Hepatocellular carcinoma by downregulating PIM1 (Retraction of Vol 92, Pg 451, 2017)
Wang, Qinggang
Jiang, Yunyun
Guo, Renle
Lv, Rongbin
Liu, Tingting
Wei, Hongji
Ming, Hanxin
Tian, Xingsong
BIOMEDICINE & PHARMACOTHERAPY, 2022, 146
[3] RETRACTION: Physcion 8-O-β-glucopyranoside exhibits anti-leukemic activity through targeting sphingolipid rheostat (Retraction of Vol 92, Pg 451, 2017)
PHARMACOLOGICAL REPORTS, 2021, 73 (01) : 321 - 321
[4] RETRACTION: Physcion 8-O-β-glucopyranoside suppresses the metastasis of breast cancer in vitro and in vivo by modulating DNMT1 (Retraction of Vol 69, Pg 36, 2017)
PHARMACOLOGICAL REPORTS, 2021, 73 (01) : 320 - 320
[5] RETRACTION: Physcion 8-O-β-Glucopyranoside Exerts Anti-Tumor Activity Against Non-Small Cell Lung Cancer by Targeting PPARγ (Retraction of Vol 302, Pg 785, 2019)
Du, Youyi
Lv, Zhuqing
Sun, Debin
Li, Yuan
Sun, Lei
Zhou, Jiafeng
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2021, 304 (12): : 2903 - 2903
[6] RETRACTION: Upregulation of miR-124 by physcion 8-O-β-glucopyranoside inhibits proliferation and invasion of malignant melanoma cells via repressing RLIP76 (Retraction of Vol 84, Pg 166, 2016)
Di Zhang
Han Yantao
Luo Xu
BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
[7] RETRACTION: MiR-137 suppresses tumor growth and metastasis in clear cell renal cell carcinoma (Retraction of Vol 70, Pg 963, 2018)
PHARMACOLOGICAL REPORTS, 2021, 73 (01) : 319 - 319
[8] RETRACTION: Physcion 8-O-β-glucopyranoside induces apoptosis, suppresses invasion and inhibits epithelial to mesenchymal transition of hepatocellular carcinoma HepG2 cells of hepatocellular carcinoma HepG2 cells (Retraction of Vol 83, Pg 372, 2016)
Wang, Qiang
Wang, Yong
Xing, Yuqing
Yan, Yi
Guo, Peng
Zhuang, Jianguang
Qin, Fawei
Zhang, Jie
BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
[9] RETRACTION: Physcion 8-O-β-glucopyranosideregulates cell cycle, apoptosis, and invasion in glioblastoma cells through modulating Skp2 (Retraction of Vol 95, Pg 1129, 2017)
Li, Wen
Li, Fuxia
Zhu, Yanfang
Song, Daqing
BIOMEDICINE & PHARMACOTHERAPY, 2021, 144
[10] RETRACTION: EMMPRIN, SP1 and microRNA-27a mediate physcion 8-O-β-glucopyranoside-induced apoptosis in osteosarcoma cells (Retraction of Vol 6, Pg 1331, 2016)
Wang, Z. H.
Yang, H. L.
AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (07): : 2202 - 2202

← 1 2 3 4 5 →